Salley G Pels MD
Instructor in Pediatrics (Hematology / Oncology); Associate Director, Yale Hemostasis Center
Clinical Interests
hematology; hemophilia; von Willebrand disease; bleeding disorders; clotting disorders; thrombophilia; thrombosis; platelet disorders; immune thrombocytopenia; alloimmune thrombocytopenia; oncology
Board Certifications
- Pediatric Hematology-Oncology, Board Eligible
- 2009
- Pediatrics, Board Certified
Patient Care Locations
salley_pelsfaculty-clinicsfalsetruefalse
Clinical Trials
| Conditions | Study Title |
|---|---|
| Recurrent or Refractory Solid Tumors | A Phase II Study of Cixutumumab (IMC-A12; IND# 100947) in Combination with Temsirolimus (IND# 61010) in Pediatric Patients with Recurrent or Refractory Solid Tumors (ADVL1221) |



